GlaxoSmithKline PLC Q1 2020 Earnings Call Summary - Thomson StreetEvents

GlaxoSmithKline PLC Q1 2020 Earnings Call Summary

GlaxoSmithKline PLC Q1 2020 Earnings Call Summary - Thomson StreetEvents
GlaxoSmithKline PLC Q1 2020 Earnings Call Summary
Published Apr 29, 2020
Published Apr 29, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of GSK.L earnings conference call or presentation 29-Apr-20 1:00pm GMT

  
Report Type:

Brief

Source:
Company:
Ticker
GSK.L
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

GlaxoSmithKline PLC at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript – 2020-09-17 – US$ 54.00 – Edited Transcript of GSK.L presentation 17-Sep-20 7:15am GMT

GlaxoSmithKline PLC at Citi BioPharma Conference (Virtual) Transcript – 2020-09-09 – US$ 54.00 – Edited Transcript of GSK.L presentation 9-Sep-20 3:40pm GMT

GlaxoSmithKline PLC Q2 2020 Earnings Call Transcript – 2020-07-29 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 29-Jul-20 1:00pm GMT

GlaxoSmithKline PLC Annual Shareholders Meeting Transcript – 2020-05-06 – US$ 54.00 – Edited Transcript of GSK.L shareholder or annual meeting 6-May-20 1:30pm GMT

GlaxoSmithKline PLC Q1 2020 Earnings Call Transcript – 2020-04-29 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 29-Apr-20 1:00pm GMT

GlaxoSmithKline PLC Q4 2019 Earnings Call Summary – 2020-02-05 – US$ 54.00 – Edited Brief of GSK.L earnings conference call or presentation 5-Feb-20 2:00pm GMT

GlaxoSmithKline PLC Q4 2019 Earnings Call Transcript – 2020-02-05 – US$ 54.00 – Edited Transcript of GSK.L earnings conference call or presentation 5-Feb-20 2:00pm GMT

GlaxoSmithKline PLC at JPMorgan Healthcare Conference Transcript – 2020-01-14 – US$ 54.00 – Edited Transcript of GSK.L presentation 14-Jan-20 3:30pm GMT

GlaxoSmithKline PLC to Discuss Pivotal DREAMM-2 Data on Belantamab Mafodotin (GSK'916) Call Summary – 2019-12-17 – US$ 54.00 – Edited Brief of GSK.L conference call or presentation 17-Dec-19 5:00pm GMT

GlaxoSmithKline PLC to Discuss Pivotal DREAMM-2 Data on Belantamab Mafodotin (GSK'916) Call Transcript – 2019-12-17 – US$ 54.00 – Edited Transcript of GSK.L conference call or presentation 17-Dec-19 5:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "GlaxoSmithKline PLC Q1 2020 Earnings Call Summary" Apr 29, 2020. Alacra Store. May 04, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2020-GlaxoSmithKline-PLC-Earnings-Call-B13115584>
  
APA:
Thomson StreetEvents. (2020). GlaxoSmithKline PLC Q1 2020 Earnings Call Summary Apr 29, 2020. New York, NY: Alacra Store. Retrieved May 04, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2020-GlaxoSmithKline-PLC-Earnings-Call-B13115584>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.